Rockefeller Financial Services’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
EIP
Rockefeller Financial Services's AZN Position: Q4 2017 in Review
Rockefeller Financial Services increased its AstraZeneca (AZN) stake by 82% in Q4 2017, buying an estimated $13.8K and bringing the position to 455 shares worth $32K. The position accounts for ﹤0.01% of the portfolio, ranked #447.
Rockefeller Financial Services first reported a position in AZN in Q4 2013 and has held it in 3 quarters since. 502 funds tracked by Wall St. Rank hold AZN as of Q4 2017.
- Rockefeller Financial Services held 455 shares of AstraZeneca worth $32K as of Q4 2017.
- Rockefeller Financial Services bought 205 AstraZeneca shares in Q4 2017, an estimated $13.8K.
- AstraZeneca made up ﹤0.01% of Rockefeller Financial Services's portfolio in Q4 2017, its #447 holding.
- Rockefeller Financial Services first reported a position in AstraZeneca in Q4 2013 and has held it in 3 quarters since.
- 502 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2017.
Based on Rockefeller Financial Services's 13F filing for Q4 2017, filed 2 Feb 2018.